Pathologic classification of rhabdomyosarcomas and correlations with molecular studies

Modern Pathology

Volumn 14, Issue 5, 2001, Pages 506-514

  Parham, David M ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b ARKANSAS CHILDREN S HOSPITAL   (United States)

Author keywords

Classification; Cytogenetics; Molecular biology; Pathology; Review; Rhabdomyosarcoma

Indexed keywords

ANAPLASTIC CARCINOMA; CYTOGENETICS; DISEASE CLASSIFICATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; RHABDOMYOSARCOMA; SPINDLE CELL SARCOMA;

ADOLESCENT; CHILD; HUMANS; PROGNOSIS; RHABDOMYOSARCOMA; SOFT TISSUE NEOPLASMS;

EID: 0035031713     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880339     Document Type: Review

References (65)

1. Miller RW, Young JL Jr, Novakovic B. Childhood cancer. Cancer 1995(1 Suppl);75:395-405.
2. Masson P. Human tumors. Histology, diagnosis, and technique. 2nd ed. Detroit, MI: Wayne State University Press; 1970.
3. Donaldson SS. Rhabdomyosarcoma. Contemporary status and future directions: The Lucy Wortham James Clinical Research Award. Arch Surg 1989;124:1015-20.
4. Stafford RA. A case of enlargement from melanoid tumor of the prostate gland in a child five years of age. Med Chir Trans 1839;22:218.
5. Wolfensberger R. Uber ein rhabdomyom der speiserohre. Beitr Pathol Anat Allg Pathol 1894;15:491.
6. Guersant MP. Polypes du vagin chez une petite fille de treize mois. Monit Hopit 1854;2:187.
7. Mahoney JP, Saffos RO. Fetal rhabdomyomatous nephroblastoma with a renal pelvic mass simulating sarcoma botryoides. Am J Surg Pathol 1981;5:297-306.
8. Parham DM. Pediatric neoplasia: morphology and biology. Philadelphia: Lippincott-Raven; 1996.
9. Newton WA Jr, Gehan EA, Webber BL, Marsden HB, van Unnik AJM, Hamoudi AB, et al. Classification of rhabdomyosarcoma and related sarcomas: pathologic aspects and proposal for a new classification - an Intergroup Rhabdomyosarcoma Study. Cancer 1995;76:1073-85.
10. Berard M. Tumeur embryonnaire du muscle striae. Lyon Med 1894;77:52.
11. Parham DM. The molecular biology of childhood rhabdomyosarcoma. Semin Diag Pathol 1994;11:39-46.
12. Reid LH, Davies C, Cooper PR, Crider-Miller SJ, Sait SN, Nowak NJ, et al. A 1-Mb physical map and PAC contig of the imprinted domain in 11p15.5 that contains TAPA1 and the BWSCR1/WT2 region. Genomics 1997;43:366-75.
13. Besnard-Guerin C, Newsham I, Winqvist R, Cavenee WK. A common region of loss of heterozygosity in Wilms' tumor and embryonal rhabdomyosarcoma distal to the D11S988 locus on chromosome 11p15.5. Hum Genet 1996;97:163-70.
14. Stout AP. Rhabdomyosarcoma of the skeletal muscles. Ann Surg 1946;123:447-72.
15. Fletcher CDM. Pleomorphic malignant fibrous histiocytoma: Fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol 1992; 16:213-28.
16. Wesche WA, Fletcher CDM, Dias P, Houghton PJ, Parham DM. Immunohistochemistry of MyoD1 in adult pleomorphic soft tissue sarcomas. Am J Surg Pathol 1995;19:261-9.
17. Newton WA Jr, Soule EH, Hamoudi AB, Reiman HM, Shimada H, Beltangady M, et al. Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma Studies I and II: clinicopathologic correlation. J Clin Oncol 1988;6:67-75.
18. Riopelle JL, Thériault JP. Sur une forme méconnue de sarcome des parties molles: le rhabdomyosarcome alvéolaire. Ann Anat Pathol 1956;1:88-111.
19. Enzinger FM, Shiraki M. Alveolar rhabdomyosarcoma: an analysis of 110 cases. Cancer 1969;24:18-31.
20. Horn RC, Enterline HT. Rhabdomyosarcoma: a clinicopathologic study of 39 cases. Cancer 1958;11:181-99.
21. Stout AP, Lattes R. Atlas of tumor pathology. 2nd series, Fascicle I: tumors of the soft tissues. Washington, DC: Armed Forces Institute of Pathology; 1967.
22. Gonzalez-Crussi F, Black-Schaffer S. Rhabdomyosarcoma of infancy and childhood: problems of morphologic classification. Am J Surg Pathol 1979;3:157-71.
23. Beckwith JB, Palmer NF. Histopathology and prognosis of Wilms tumors: results from the First National Wilms' Tumor Study. Cancer 1978;41:1937-48.
24. Palmer NF, Foulkes M. Histopathology and prognosis in the second Intergroup Rhabdomyosarcoma Study (IRS II) [Abstract]. Proc ASCO 1983;2:229.
25. Palmer NF, Sachs N, Foulkes M. Histology and prognosis in rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study [Abstract]. Proc SIOP 1981;13:113.
26. Palmer NF, Sachs N, Foulkes M. Histology and prognosis in rhabdomyosarcoma (IRS-I) [Abstract]. Proc ASCO 1982;1: 170.
27. Caillaud JM, Gérard-Marchant R, Marsden HB, van Unnik AJM, Rodary C, Rey A, et al. Histopathologic classification of childhood rhabdomyosarcoma: a report from the International Society of Pediatric Oncology Pathology Panel. Med Pediatr Oncol 1989;17:391-400.
28. Wijnaendts LCD, van der Linden JC, van Unnik AJM, Delemarre JFM, Voute PA, Meijer CJLM. Histologic classification of childhood rhabdomyosarcomas: relationship with clinical parameters and prognosis. Hum Pathol 1994;25:900-7.
29. Tsokos M, Webber B, Parham D, Wesley R, Miser A, Miser JS, et al. Rhabdomyosarcoma: a new classification scheme related to prognosis. Arch Pathol Lab Med 1992;116:847-55.
30. Parham DM, Shapiro DN, Downing JR, Webber BL, Douglass EC. Solid alveolar rhabdomyosarcomas with the t(2;13): report of two cases with diagnostic implications. Am J Surg Pathol 1994;18:474-8.
31. The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer 1982;49:2112-35.
32. Asmar L, Gehan EA, Newton WA, Webber BL, Marsden HB, van Unnik AJM, et al. Agreement among and within groups of pathologists in the classification of rhabdomyosarcoma and related childhood sarcomas: report of an international study of four pathology classifications. Cancer 1994;74:2579-88.
33. Qualman SJ, Coffin CM, Newton WA, Hojo H, Triche TJ, Parham DM, et al. Intergroup Rhabdomyosarcoma Study. Update for pathologists. Pediatr Dev Pathol 1998;1:550-61.
34. Pappo AS, Shapiro DN, Crist WM, Maurer HM. Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol 1995; 13:2123-39.
35. Tobar A, Avigad S, Zoldan M, Mor C, Goshen Y, Zaizov R. Clinical relevance of molecular diagnosis in childhood rhabdomyosarcoma. Diagn Mol Pathol 2000;9:9-13.
36. Anderson J, Renshaw J, McManus A, Carter R, Mitchell C, Adams S, et al. Amplification of the t(2;13) and t(1;13) translocations of alveolar rhabdomyosarcoma in small formalin-fixed biopsies using a modified reverse transcriptase polymerase chain reaction. Am J Pathol 1997;150:477-82.
37. Hachitanda Y, Toyoshima S, Akazawa K, Tsuneyoshi M. N-myc gene amplification in rhabdomyosarcoma detected by fluorescence in situ hybridization: its correlation with histologic features. Mod Pathol 1998;11:1222-7.
38. Cavazzana AO, Schmidt D, Ninfo V, Harms D, Tollot M, Carli M, et al. Spindle cell rhabdomyosarcoma: A prognostically favorable variant of rhabdomyosarcoma. Am J Surg Pathol 1992;16:229-35.
39. Leuschner I, Newton WA Jr, Schmidt D, Sachs N, Asmar L, Hamoudi A, et al. Spindle cell variants of embryonal rhabdomyosarcoma in the paratesticular region: A report of the Intergroup Rhabdomyosarcoma Study. Am J Surg Pathol 1993;17:221-30.
40. Kodet R, Newton WA Jr, Hamoudi AB, Asmar L, Jacobs DL, Maurer HM. Childhood rhabdomyosarcoma with anaplastic (pleomorphic) features: a report of the Intergroup Rhabdomyosarcoma Study. Am J Surg Pathol 1993;17:443-53.
41. Pascasio J, Triche T, Sorensen P, Barr F, Qualman S. p53 expression correlates with anaplasia in rhabdomyosarcoma (RMS) [Abstract]. Mod Pathol 2000;11:4P.
42. Khan J, Bittner ML, Saal LH, Teichmann U, Azorsa DO, Gooden GC, et al. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc Natl Acad Sci U S A 1999;96:13264-9.
43. Downing JR, Khandekar A, Shurtleff SA, Head DR, Parham DM, Webber BL, et al. Multiplex RT-PCR assay for the differential diagnosis of alveolar rhabdomyosarcoma and Ewing's sarcoma. Am J Pathol 1995;146:626-34.
44. Kelly KM, Womer RB, Sorensen PH, Xiong QB, Barr FG. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. J Clin Oncol 1997;15: 1831-6.
45. Kullendorff CM, Donner M, Mertens F, Mandahl N. Chromosomal aberrations in a consecutive series of childhood rhabdomyosarcoma. Med Pediatr Oncol 1998;30:156-9.
46. Scrable H, Witte D, Shimada H, Seemayer T, Wang-Wuu S, Soukup S, et al. Molecular differential pathology in rhabdomyosarcoma. Genes Chromosomes Cancer 1989;1:23-35.
47. Koufos A, Hansen MF, Copeland NG, Jenkins NA, Lampkin BC, Cavenee WK. Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism. Nature 1985;316:330-4.
48. Sotelo-Avila C, Gooch WM. Neoplasms associated with the Beckwith-Wiedemann syndrome. Perspect Pediatr Pathol 1976;3:255-72.
49. Scrable H, Cavenee W, Ghavimi F, Lovell M, Morgan K, Sapienza C. A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting. Proc Natl Acad Sci U S A 1989;86:7480-4.
50. Zhan S, Shapiro DN, Helman LJ. Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma. J Clin Invest 1994;94:445-8.
51. Chen B, Dias P, Jenkins JJ, Savell VH, Parham DM. Methylation alterations of the MyoD1 upstream region are predictive of subclassification of human rhabdomyosarcomas. Am J Pathol 1998;152:1071-9.
52. Chen B, He L, Savell VH, Jenkins JJ, Parham DM. Inhibition of the interferon-gamma/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region. Cancer Res 2000;60:3290-8.
53. Jung WH, Jung SH, Yoo CJ, Kim YJ, Park C, Kim BS. Flow cytometric analysis of DNA ploidy in childhood rhabdomyosarcoma. Yonsei Med J 1994;35:34-42.
54. Niggli FK, Powell JE, Parkes SE, Ward K, Raafat F, Mann JR, et al. DNA ploidy and proliferative activity (S-phase) in childhood soft-tissue sarcomas: their value as prognostic indicators. Br J Cancer 1994;69:1106-10.
55. Bridge JA, Liu J, Weibolt V, Baker KS, Perry D, Kruger R, et al. Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an intergroup rhabdomyosarcoma study. Genes Chromosomes Cancer 2000;27: 337-44.
56. Lee W, Han K, Harris CP, Meisner LF. Detection of aneuploidy and possible deletion in paraffin-embedded rhabdomyosarcoma cells with FISH. Cancer Genet Cytogenet 1993; 68:99-103.
57. Smith SS. Stalling of DNA methyltransferase in chromosome stability and chromosome remodelling. Int J Mol Med 1998; 1:147-56.
58. Vilain A, Vogt N, Dutrillaux B, Malfoy B. DNA methylation and chromosome instability in breast cancer cell lines. FEBS Lett 1999;460:231-4.
59. Xu GL, Bestor TH, Bourc'his D, Hsieh CL, Tommerup N, Bugge M, et al. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 1999;402:187-91.
60. Dias P, Chen B, Dilday B, Palmer H, Hosoi H, Singh S, et al. Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass. Am J Pathol 2000;156:399-408.
61. Pinto A, Tallini G, Novak RW, Bowen T, Parham DM. Undifferentiated rhabdomyosarcoma with lymphoid phenotype expression. Med Pediatr Oncol 1997;28:165-70.
62. Boue D, Parham D, Webber B, Maurer H, Qualman S. Clinicopathologic study of pediatric ectomesenchymoma from IRS III and IV [Abstract]. Mod Pathol 1997;10:2P.
63. Etcubanas E, Peiper S, Stass S, Green A. Rhabdomyosarcoma, presenting as disseminated malignancy from an unknown primary site: a retrospective study of ten pediatric cases. Med Pediatr Oncol 1989;17:39-44.
64. Coffin CM, Rulon J, Smith L, Bruggers C, White FV. Pathologic features of rhabdomyosarcoma before and after treatment: a clinicopathologic and immunohistochemical analysis. Mod Pathol 1997;10:1175-87.
65. Andrassy RJ, Wiener ES, Raney RB, Hays DM, Arndt CA, Lobe TE, et al. Progress in the surgical management of vaginal rhabdomyosarcoma: a 25-year review from the Intergroup Rhabdomyosarcoma Study Group. J Pediatr Surg 1999;34: 731-4.